AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
ASCENTAGE PHARMA GROUP INTERNATIONAL
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 29, 2026
$15.36−0.01 (-0.07%)
Close on Oct 19, 2026
Share price
−$20.08 (−56.66%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
ASCENTAGE PHARMA GROUP INTERNATIONAL grew revenue 341.8% to CN¥980.65M over fiscal 2024. Free cash flow was -CN¥135.65M.
Revenue
CN¥980.65M
+341.8% vs. a year earlier
Free cash flow
-CN¥135.65M
FY2024
EPS, diluted
-1.34 CNY
FY2024
Key statistics
Valuation at the latest close; fundamentals over fiscal 2024, balances at Dec 31, 2024
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- CN¥980.65M
- Net income
- -CN¥405.43M
- EPS, diluted
- -1.34 CNY
- Free cash flow
- -CN¥135.65M
Valuation needs the share price. It fills in once daily prices are connected and converted from CNY.
Four years at a glance
Fiscal years 2021 to 2024, CNY
Revenue
CN¥980.65M+341.8% YoY
Gross profit
CN¥951.57M+397.1% YoY
Net income
-CN¥405.43M
EPS, diluted
-1.34 CNY
Free cash flow
-CN¥135.65M
Reported period